Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DR26FMH0E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,388
Award facts
- Contract value 100% obligated
- $2,387.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for $2,387.94 to supply HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable pharmaceutical product used in rheumatological and other therapeutic applications. The contract is competitively awarded without set-aside designation and employs firm fixed price terms, with a completion target of November 21, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract history demonstrates capability across diverse pharmaceutical categories including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This specific delivery order for HUMIRA represents one of numerous routine pharmaceutical transactions executed under the company's prime vendor agreement, enabling efficient fulfillment of ongoing medical supply requirements for military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FMH0E?
SPE2DR26FMH0E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FMH0E worth?
The government has obligated $2,388 on SPE2DR26FMH0E.
Is contract SPE2DR26FMH0E an order under another contract?
Yes. SPE2DR26FMH0E is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMH0E competed?
The extent of competition for SPE2DR26FMH0E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award